[Yingli Green Energy Reports Fourth Quarter and Full Year 2010 Results Sustainable Profitability Supported by Historical High Shipment and 32.9% Gross Margin BAODING, China, February 18, 2011 Fourth Quarter 2010 Consolidated Financial and Operating Highlights Total net revenues were RMB 4,066.2 million (US$616.1 million) and PV module shipment increased by 21.6% quarter over quarter, reaching a historical high. ]
[Yingli Green Energy Reports Fourth Quarter and Full Year 2010 Results Sustainable Profitability Supported by Historical High Shipment and 32.9% Gross Margin BAODING, China, February 18, 2011 Fourth Quarter 2010 Consolidated Financial and Operating Highlights Total net revenues were RMB 4,066.2 million (US$616.1 million) and PV module shipment increased by 21.6% quarter over quarter, reaching a historical high. ]
[eLong Reports Fourth Quarter and Full Year 2010 BEIJING, China February 17, 2011 eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for the fourth quarter and full year ended December 31, 2010. Highlights Fourth Quarter 2010 Net revenues for the fourth quarter Income from operations for]
[eLong Reports Fourth Quarter and Full Year 2010 BEIJING, China February 17, 2011 eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for the fourth quarter and full year ended December 31, 2010. Highlights Fourth Quarter 2010 Net revenues for the fourth quarter Income from operations for]
[] [Biostar Pharmaceuticals to Host Virtual Presentation February 18th at 10:30 AM EST XIANYANG, China, Feb. 17, 2011 -- Biostar Pharmaceuticals, Inc. (Nasdaq: BSPM) ("Biostar" or "the Company"), Xianyang, PRC-based manufacturer of an over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of other pharmaceutical products in the PRC, today announced that Bill Chen, CFO, will host a]
[ex99-1.htm 2 EX-99.1] [Biostar Pharmaceuticals to Host Virtual Presentation February 18th at 10:30 AM EST XIANYANG, China, Feb. 17, 2011 -- Biostar Pharmaceuticals, (Nasdaq: BSPM) ("Biostar" or "thempany"), Xianyang,-based manufacturer of an over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acidpsules, and a variety of other pharmaceutical products in the today announced that Bill Chen, CFO, will host a]
[February 18, 2011 Via Facsimile and EDGAR Assistant Director Division of Corporation Finance 100 F Street, N.E. Re: KongZhong Corporation Annual Report on Form 20-F for the Fiscal Year ended December 31, 2009 filed on June 4, 2010 (File No. 000-50826) Dear Mr. Spirgel: For your convenience, the Company has included the Staff’s comments in this response letter in italicized]
[February 18, 2011 Via Facsimile and EDGAR Assistant Director Division of Corporation Finance 100 F Street, N.E. Re: KongZhong Corporation Annual Report on Form 20-F for the Fiscal Year ended December 31, 2009 filed on June 4, 2010 (File No. 000-50826) Dear Mr. Spirgel: For your convenience, the Company has included the Staff’s comments in this response letter in italicized]
[ENTERTAINMENT GAMING ASIA INC. Nevada 001-32161 91-1696010 (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification Number) Unit 3705, 37/F, The Centrium 60 Wyndham Street Central, Hong Kong + 852-3151-3800 Not Applicable (Former name or former address, if changed since last report) o]
[ENTERTAINMENT GAMING ASIA INC. Nevada 001-32161 91-1696010 (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification Number) Unit 3705, 37/F, The Centrium 60 Wyndham Street Central, Hong Kong + 852-3151-3800 Not Applicable (Former name or former address, if changed since last report) o]
